Off-label prescriptions and decisions on reimbursement requests in Germany - a retrospective analysis-Reference-Cited by-同舟云学术

Off-label prescriptions and decisions on reimbursement requests in Germany - a retrospective analysis

Published:2017-10-24 Issue:11 Volume:15 Page:1103-1109
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Seidenschnur Karin Ellen Katharina¹,Dressler Corinna¹,Weller Karsten²,Nast Alexander¹,Werner Ricardo Niklas¹

Affiliation:

1. Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Department of Dermatology, Venerology and Allergology, Division of Evidence based Medicine (dEBM)

2. Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venerology and Allergology

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ddg.13345/fullpdf

Reference11 articles.

1. Off-label use in dermatological practice. The conflict between professional duty and legal requirements;Brunne;Hautarzt,2004

2. Off-label use in dermatology in Germany: What has changed since 2004?;Brockmeyer;J Dtsch Dermatol Ges,2009

3. Federal Ministry of Health in Germany (Bundesministerium für Gesundheit) Maßnahmen zur Verbesserung der gesundheitlichen Situation von Menschen mit Seltenen Erkrankungen in Deutschland. 2009

4. VFA Association of Research-Based Pharmaceutical Companies in Germany (Die forschenden Pharma-Unternehmen). Was der Orphan Drug-Status für ein Medikament bedeutet (und was nicht). 2016

5. Off-label use and G-BA. Legal framework for off-label use;Brucklacher;Hautarzt,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and facilitators to guideline for the management of pediatric off-label use of drugs in China: a qualitative descriptive study;BMC Health Services Research;2024-04-05

2. Patients’ experiences with methylcobalamin injections in amyotrophic lateral sclerosis;Brain Circulation;2024-01

3. Radiochirurgie vs. Ganzhirnbestrahlung – mehr Lebensqualität, mehr Leistungsfähigkeit?;Die Onkologie;2022-09-14

4. Management guideline for the off-label use of medicine in China (2021);Expert Review of Clinical Pharmacology;2022-09-11

5. DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment;Strahlentherapie und Onkologie;2022-08-29